Article · 26 Aug 2026
Review articlePublished 27 Dec 2022
USE OF IVERMECTIN IN COVID-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The emergence of Coronavirus infection has produced a concerning scenario all across the world. COVID-19 is made up of a single stranded positive sense RNA gene that is wrapped in a crown shaped collection of spike glycoproteins in an external membrane. Depending on the person's genetics, race, age and geographic region, COVID-19 infection can cause a range of symptoms and morbidity. Pulmonary epithelial cell death, thrombosis, hyper coagulation and vascular leak are all part of COVID-19 pathophysiology, which can lead to sepsis in severe instances. As a result of these events, Acute Respiratory Distress Syndrome (ARDS) and lung fibrosis occur. The vital to create a therapeutic approach is to stop COVID-19 from spreading. COVID-19 instances are on the rise every day, yet there is no effective therapy or vaccine available. Several clinical studies are being done in COVID-19 to assess the effectiveness of various drugs and vaccinations. To yet, no one medication has been discovered to be successful for Coronavirus patients. This analysis examines the proof for using ivermectin, an anti-parasitic drug with antiviral properties. Ivermectin, an FDA approved medicine which is used to treat parasitic infection, was lately discovered to have a suppressive impact on Coronavirus. It possesses antiviral activity in vitro and in vivo against a number of viruses, in addition to anti-parasitic capabilities. As a result of this antiviral effect, it has been identified as a potential COVID treatment drug. In vitro, ivermectin was been demonstrated to be inhibitory to RNA and DNA viruses. The goal of this theoretical article is to assess the available information on COVID-19 transcription features and to explain the method of action of ivermectin, which may justify its therapeutic use in COVID-19 treatment.
Subjects
Dentistry & Oral HealthAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Research in Medical and Dental Science.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Research in Medical and Dental Science
- SubjectDentistry & Oral Health
- BylineArticles whose byline prints “Sarvesh Ravi Kandoi”
- BylineArticles whose byline prints “Pramita Gharde”
- BylineArticles whose byline prints “Ashok Mehendale”